Biyoteknoloji · Aseptik İşleme
In biotech and sterile manufacturing, mopping is not about appearance. It is a controlled disinfection protocol embedded in the Contamination Control Strategy (CCS).
In aseptic filling and cell culture suites, contamination threats are invisible: viable microorganisms, sub-visible particulates, and pyrogens. The objective is contamination control—not cosmetic cleanliness.
Bu mantık şuna uygundur: Endüstriye ve Sınıfa Göre Temiz Oda Paspası Biyoteknoloji ortamlarının mikrobiyolojik ve moleküler risk kontrolüne öncelik verdiği karar çerçevesi.
A sterile mop is not necessarily a low-endotoxin mop. Endotoxins are heat-stable and may survive sterilization, making upstream material control critical.
Ayrıca bakınız: Steril ve Aseptik Temiz Oda Paspası
Non-Volatile Residue (NVR) can accumulate as disinfectants evaporate, creating films that trap particulates or support microbial persistence.
For ISO Class 5 environments, continuous-filament polyester with sealed edges is recommended. Reference: ISO Temiz Oda Paspas Kılavuzu
In biotech cleanrooms, mopping is about controlling liquid delivery, wet contact time, and chemical compatibility.
Inconsistent release compromises validated contact time, leading to ineffective disinfection.
Mop materials must withstand peracetic acid and hydrogen peroxide without degradation.
İlaç sektörüne yönelik siteler için şunları inceleyin: Farmasötik Temiz Oda Paspası Ve GMP Temiz Oda Paspası.
In biotech and aseptic processing, mopping is a sterility assurance activity, not a housekeeping task. When treated as a validated disinfection system, it strengthens the Contamination Control Strategy and audit readiness.
QA Yöneticileri için Sonraki Adım:
Request a supplier qualification checklist covering endotoxin,
NVR, sterility assurance, and batch traceability.
